Brussels: On Nov 9, the European Union drugs regulator is all ready to approve the use of two monoclonal antibodies to deal with COVID-19 patients in near future. The immediate decision came as the bloc encounters a new surge in infections and hospitalization even with high vaccination in many countries. Both medications are presently used to treat COVID-19 patients at risk of developing a drastic infection.
